UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

STAT3 in the systemic inflammation of cancer cachexia

Seminars in cell & developmental biology, 2016-06, Vol.54, p.28-41

2016

Volltextzugriff (PDF)

Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition

Current opinion in supportive & palliative care, 2018-12, Vol.12 (4), p.420-426

2018

Volltextzugriff (PDF)

Role of myokines and osteokines in cancer cachexia

Experimental biology and medicine (Maywood, N.J.), 2021-10, Vol.246 (19), p.2118-2127

2021

Volltextzugriff (PDF)

Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism

Journal of cachexia, sarcopenia and muscle, 2019-02, Vol.10 (1), p.140-154

2019

Volltextzugriff (PDF)

Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia

The Journal of experimental medicine, 2021-06, Vol.218 (6)

2021

Volltextzugriff (PDF)

Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways

Frontiers in physiology, 2016-10, Vol.7, p.472-472

2016

Volltextzugriff (PDF)

JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia

American journal of physiology: endocrinology and metabolism, 2012-08, Vol.303 (3), p.E410-E421

2012

Volltextzugriff (PDF)

MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer

International journal of molecular sciences, 2021-02, Vol.22 (3), p.1486

2021

Volltextzugriff (PDF)

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Journal of visualized experiments, 2016-11 (117)

2016

Volltextzugriff (PDF)

STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia

PloS one, 2011-07, Vol.6 (7), p.e22538-e22538

2011

Volltextzugriff (PDF)

PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia

The FASEB journal, 2019-06, Vol.33 (6), p.7778-7790

2019

Volltextzugriff (PDF)

Reduced rDNA transcription diminishes skeletal muscle ribosomal capacity and protein synthesis in cancer cachexia

The FASEB journal, 2021-02, Vol.35 (2), p.e21335-n/a

2021

Volltextzugriff (PDF)

HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia

Disease models & mechanisms, 2020-01, Vol.13 (1)

2020

Volltextzugriff (PDF)

The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice

Frontiers in cell and developmental biology, 2022-03, Vol.10, p.861622-861622

2022

Volltextzugriff (PDF)

PGC1α overexpression preserves muscle mass and function in cisplatin‐induced cachexia

Journal of cachexia, sarcopenia and muscle, 2022-10, Vol.13 (5), p.2480-2491

2022

Volltextzugriff (PDF)

Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice

Bone (New York, N.Y.), 2019-07, Vol.124, p.89-102

2019

Volltextzugriff (PDF)

Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia

Journal of cachexia, sarcopenia and muscle, 2018-08, Vol.9 (4), p.685-700

2018

Volltextzugriff (PDF)

Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia

Cancers, 2021-02, Vol.13 (4), p.850

2021

Volltextzugriff (PDF)

Impact of Sarcopenia on Outcomes of Autologous Head and Neck Free Tissue Reconstruction

Journal of reconstructive microsurgery, 2020-06, Vol.36 (5), p.369-378

2020

Volltextzugriff (PDF)

Molecular Mechanisms Responsible for the Rescue Effects of Pamidronate on Muscle Atrophy in Pediatric Burn Patients

Frontiers in endocrinology (Lausanne), 2019-08, Vol.10, p.543-543

2019

Volltextzugriff (PDF)

Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice

Frontiers in endocrinology (Lausanne), 2019-11, Vol.10, p.809-809

2019

Volltextzugriff (PDF)

Effect of the specific proteasome inhibitor bortezomib on cancer‐related muscle wasting

Journal of cachexia, sarcopenia and muscle, 2016-06, Vol.7 (3), p.345-354

2016

Volltextzugriff (PDF)

Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments

Cells (Basel, Switzerland), 2021-02, Vol.10 (3), p.516

2021

Volltextzugriff (PDF)

Muscle atrophy in experimental cancer cachexia: Is the IGF‐1 signaling pathway involved?

International journal of cancer, 2010-10, Vol.127 (7), p.1706-1717

2010

Volltextzugriff (PDF)

Transcriptome Profiling Reveals Matrisome Alteration as a Key Feature of Ovarian Cancer Progression

Cancers, 2019-10, Vol.11 (10), p.1513

2019

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(162)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(99)
Humans
(48)
Cachexia
(35)
Animals
(34)
Mice
(27)
Male
(26)
Skeletal Muscle
(22)
Musculoskeletal System
(21)
Cancer
(20)
Female
(20)
Chemotherapy
(19)
Technology
(17)
Cachexia - Etiology
(16)
Muscle Wasting
(16)
Oncology
(15)
Physical Sciences
(14)
Science & Technology - Other Topics
(14)
Metabolism
(13)
Muscle, Skeletal - Pathology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

STAT3 in the systemic inflammation of cancer cachexia

Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition

Role of myokines and osteokines in cancer cachexia

Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism

Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia

Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways

JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia

MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia

PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia

Reduced rDNA transcription diminishes skeletal muscle ribosomal capacity and protein synthesis in cancer cachexia

HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia

The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice

PGC1α overexpression preserves muscle mass and function in cisplatin‐induced cachexia

Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice

Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia

Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia

Impact of Sarcopenia on Outcomes of Autologous Head and Neck Free Tissue Reconstruction

Molecular Mechanisms Responsible for the Rescue Effects of Pamidronate on Muscle Atrophy in Pediatric Burn Patients

Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice

Effect of the specific proteasome inhibitor bortezomib on cancer‐related muscle wasting

Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments

Muscle atrophy in experimental cancer cachexia: Is the IGF‐1 signaling pathway involved?

Transcriptome Profiling Reveals Matrisome Alteration as a Key Feature of Ovarian Cancer Progression

Suchergebnisse filtern